Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
162 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Credit Valley Hospital
Mississauga, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Royal Victoria Hospital - Montreal
Montreal, Quebec, Canada
- St. Mary'S Hospital Center
Montreal, Quebec, Canada
- Hopital Du Saint-Sacrement, Quebec
Québec, Quebec, Canada
- Mbccop - San Juan
San Juan, Puerto Rico
- Comprehensive Cancer Institute of Huntsville
Huntsville, Alabama, United States
- Ccop - Greater Phoenix
Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- California Cancer Center
Fresno, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Scripps Cancer Center
La Jolla, California, United States
- Loma Linda University Cancer Institute
Loma Linda, California, United States
- Pacific Shores Medical Group
Long Beach, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Comprehensive Cancer Centers of the Desert
Palm Springs, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Kaiser Permanente Medical Center/kaiser Foundation Hospital - San Diego
San Diego, California, United States
- Ccop - Santa Rosa Memorial Hospital
Santa Rosa, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Kaiser Permanente Medical Center - Vallejo
Vallejo, California, United States
- Ccop - Colorado Cancer Research Program, Incorporated
Denver, Colorado, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- University of Connecticut
Farmington, Connecticut, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- George Washington University Medical Center
Washington D.C., District of Columbia, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- Halifax Medical Center
Daytona Beach, Florida, United States
- Baptist Regional Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2001
- Primary completion
- 31 Oct 2003
- Completion
- 28 Feb 2011
- Last update posted
- 19 Apr 2011
- Registered enrollment
- 1,598
- Registry id
- NCT00016432
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.